Related Experiment Video
Updated: Jul 14, 2026

Establishment of a Clinic-based Biorepository
Published on: May 29, 2017
Differential PIAS3 expression in human malignancy
1Deptartment of Cancer Biology, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA. wangl@ccf.org
Abstract:
STAT3 mediated signaling pathways can be inhibited by PIAS3 (protein inhibitor of activated STAT3), which was recently found to regulate protein stability and function by its SUMO (small-ubiquitin like modifiers) ligase activity in promoting sumoylation of important nuclear proteins. Over-expression of PIAS3 can induce apoptosis in prostate cancer cell lines both in vitro and in vivo. Checking endogenous PIAS3 expression in various human specimens by immunohistochemistry, we report that basal amounts of PIAS3 exist in the nucleus in a majority of epithelial and endothelial cells. Increased PIAS3 expression was observed in 100/103 samples examined in a variety of human cancers including lung, breast, prostate, colon-rectum, and brain tumors. Differential PIAS3 expression and the specific patterns may be useful as a molecular marker of human cancer.
Insights
Protein inhibitor of activated STAT3 (PIAS3) regulates protein stability and can induce apoptosis in cancer cells. Increased PIAS3 expression is observed in various human cancers, suggesting its potential as a cancer biomarker.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- STAT3 signaling pathways are crucial in cell regulation.
- PIAS3 (protein inhibitor of activated STAT3) inhibits STAT3 signaling.
- PIAS3 regulates protein stability and function via SUMOylation.
Purpose of the Study:
- To investigate the role of PIAS3 in cancer.
- To determine if PIAS3 expression levels can serve as a cancer biomarker.
Main Methods:
- Studied PIAS3's SUMO ligase activity.
- Examined PIAS3's effect on prostate cancer cell lines (in vitro and in vivo).
- Analyzed endogenous PIAS3 expression in human cancer specimens using immunohistochemistry.
Main Results:
- PIAS3 overexpression induced apoptosis in prostate cancer cells.
- Basal PIAS3 expression was detected in the nucleus of normal epithelial and endothelial cells.
- Elevated PIAS3 expression was found in 100/103 human cancer samples, including lung, breast, prostate, colon-rectum, and brain tumors.
Conclusions:
- PIAS3 plays a role in inducing apoptosis in cancer cells.
- Differential PIAS3 expression patterns in cancer tissues may indicate its utility as a molecular marker for human cancers.
More Related Videos
10:21Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
Published on: September 20, 2024
09:01Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025
Related Concept Videos
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...